- Display 15 Products per page
Published: November 6, 2013 | Price: $3,995.00 – $7,990.00
The World Market for Immunoassays Visit our Immunoassays curated page for complete industry coverage. The immunoassay market is large and long-established, but at the same time highly competitive. Kalorama Information’s newly published report, The World Market for Immunoassays, describes the opportunities that exist for large IVD companies adopting new strategies and for new entrants to take market share. Immunoassays have been used in clinical laboratory medicine since the 1960s, and are indispensable tools in clinical diagnostics. A wide range of...Published: November 22, 2013 | Price: $1,995.00 – $4,000.00
The World Market for Hematology Used for both critical and routine testing, hematology is a central part of IVD. CBCs contribute to the general assessment of health for patients during regular check-ups. Conditions such as anemia, other blood disorders, infection, allergy, iron and vitamin deficiencies are easily diagnosed through a CBC. This report, authored by Kalorama Analyst Emil Salazar, defines the market worldwide for analyzers, point of care tests, stains and slides and imaging systems used in hematology testing. Hematology...Published: December 16, 2013 | Price: $995.00 – $1,990.00
Full coverage of the IVD market in Mexico, including important IVD segments.Published: December 20, 2013 | Price: $3,995.00 – $7,990.00
The market for clinical lab services is dynamic. It is estimated that approximately 80% of physician's diagnoses are a result of laboratory tests, and a fair number of these tests are sent to clinical lab service providers. There is constant pressure to reduce healthcare spending, and that in turn is shifting healthcare utilization in favor of the laboratory. This has not escaped the attention of major competitors who operate in the industry, and those planning to enter. Clinical Laboratory Services...Published: January 1, 2014 | Price: $1,995.00 – $3,995.00
IVD in Singapore and Malaysia Regional opportunities are the focus of IVD manufacturers that seek marginal growth. Southeast Asia represents a unique market for healthcare providers and their various business suppliers, including the in vitro diagnostics (IVD) industry. Kalorama details in this report two countries expected to provide business for IVD manufacturers: Singapore and Malaysia. IVD in Singapore and Malaysia contains the following information: Healthcare Statistics for Singapore and Malaysia Significant Hospitals in both countries The Clinical Lab Market in...Published: January 14, 2014 | Price: $995.00 – $1,990.00
Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the diagnostics market. Many molecular tests are CE Marked and FDA-cleared and many more are in development. However many more unique tests have been launched as test services, especially for cancer management and infectious disease epidemiology. In light of the amount of activity in test development and regulatory and reimbursement challenges in 2013, Kalorama Information presents this updated review of molecular...Published: February 5, 2014 | Price: $1,995.00 – $3,995.00
IVD manufacturers on the lookout for growth have targeted the Philippines among other places. Expanding economies worldwide need to increase healthcare spending to satisfy growing middle and low-to-middle class populations. IVD performs where healthcare spending increases as it is often the entry point of healthcare. This report, IVD Distribution in The Philippines, reviews the distribution of in vitro diagnostic products in this growing Asian Market. IVD in the Philippines includes: What Products Lines Are Distributed by Which Philippine IVD Companies...Published: February 5, 2014 | Price: $1,995.00 – $3,990.00
Medical Imaging Markets (X-Ray, CT, MRI, Ultrasound, PET, SPECT, Others) Medical imaging’s contributions to medical practice has made it an ever-growing industry with new technologies constantly being launched. Early and more accurate diagnoses are made possible via imaging scans, which in turn may lead to optimized treatment regimens. The Medical Imaging Markets report reviews current and potential world opportunities for medical imaging systems, which include x-ray, mammography, fluoroscopy, CT, MRI, Ultrasound, PET and SPECT, and fusion systems. This study forecasts...Published: February 5, 2014 | Price: $2,995.00 – $5,990.00
The Market and Potential for Molecular Point of Care Diagnostics Molecular Point of Care is a budding field in medical diagnostics. Kalorama's report, The Market and Potential for Molecular Point of Care Diagnostics, provides the most current look at this field. To assess the opportunity, Kalorama's report examines the molecular diagnostics business and also the point-of-care (POC) diagnostics business as they are now, and then examines at the new combination products. A good number of companies are producing or...Published: March 18, 2014 | Price: $1,995.00 – $3,990.00
The United States is the world’s largest in vitro diagnostics and nearly half of the global IVD market. While companies seek emerging markets for growth, most healthcare business is generated in the United States and its volume is still a strong advantage of this market. Most recently the U.S. IVD market weathered interrupted lab and healthcare sector investment in anticipation of the Affordable Care Act and several regulatory and austerity measures on the part of government payers that constricted payments...Published: April 16, 2014 | Price: $600.00 – $1,200.00
Results of the 2014 (Jan-Feb 2014) survey of glucose meter users.Published: June 16, 2014 | Price: $995.00 – $1,990.00
The World Market for Flow Cytometry in IVD Applications Flow cytometers are powerful reference lab instruments that are now an important component of advanced IVD labs in developed nations. They are advanced diagnostic instruments for cancer diagnostics, but their newer clinical applications included the commercialization and refinement of HIV testing and monitoring through CD4/CD8 counts. Until recently flow cytometry has been used exclusively for these purposes. Other applications are seeing procedure growth. This report, The World Market for Flow Cytometry...Published: July 14, 2014 | Price: $995.00 – $1,990.00
Drugs of Abuse is an important growth category in IVD testing with competitive participation by top IVD vendors for market share. Healthcare professionals, employers, criminal justice personnel, and sports use drug tests as part of a comprehensive evaluation of individuals to reach a correct decision regarding the individuals’ actions, behaviors or performances. This report covers trends and markets in drugs of abuse testing. As part of its coverage, the report offers estimates and forecasts for drugs of abuse markets, and...Published: August 8, 2014 | Price: $995.00 – $1,990.00
Companion Diagnostics Markets (Cancer, Cardiovascular and Blood, Metabolic, Infection, Neurological, Others) Companion drug/test products are of great interest to pharmaceutical companies, testmakers, as well as investors and entrpreneurs. The global market is increasing, and test/product development is increasing as an area of development for pharma companies. Many companion products are now successfully marketed, especially for cancer treatment. Several are part of routine diagnostic and treatment. This report explains events in the market and provides lists of companion products. It also...Published: August 13, 2014 | Price: $1,995.00 – $3,990.00
The in vitro diagnostics (IVD) market attracts considerable interest. There are hundreds of participating companies, competing in multiple areas of testing. Each IVD segment could be said to function as an industry in and of itself. There are companies who specialize in one area and companies who participate across segments. There are myriad products, from routine blood tests to complicated molecular assays and new sequencing based technologies. It's often necessary for competitors to know about all of the segments of testing as different technologies can...